Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Thorax ; 77(Suppl 1):A202-A203, 2022.
Article in English | ProQuest Central | ID: covidwho-2118621

ABSTRACT

IntroductionPatients hospitalised with COVID-19 are susceptible to chronic symptoms that can impact their health-related quality of life (HRQL). There is a limited understanding of the timeline of these symptoms or predictors of poorer HRQL outcomes in this patient cohort.We compared HRQL symptoms;specifically mobility, breathlessness, and anxiety and depression in patients pre- and post- hospitalisation with COVID-19, to identify any predictors of persistent symptoms.Method350 patients admitted with COVID-19 to Royal Berkshire Hospital between March 2020 and September 2021 were included. Symptom data was captured using the validated EQ-5D-5L questionnaire with pre-COVID scores (week 0), recorded retrospectively at time of discharge or at 6 weeks, compared with scores at 6- and 12-weeks post hospital discharge. Statistical analyses used a one-tailed dependent t-test to compare scores between the time points and logistic regression examined the influence of comorbidity burden, ICU admission and length of stay.ResultsComplete data was available for n=350 (61% male, mean age 57.8 years, SD 12.81). All patients required supplementary oxygen therapy with 79% requiring non-invasive ventilation and 16.62% mechanical ventilation. A statistically significant improvement was found in mobility, breathlessness and anxiety and depression scores at 12 weeks compared to 6 weeks. Overall HRQL scores were lower at week 0 than at week 12 (mean=5.6, SD 2.66 vs. mean=5.78, SD 5.46, p=0.0434), indicating a poorer HRQL outcome at 12 weeks compared to pre-COVID. Thus, the t-test result for the null hypothesis (HRQL at 0 weeks ≤HRQL at 12 weeks) was not statistically significant. There was no statistically significant difference on score outcomes of patients who required ICU compared to ward-based care. Pre-existing pulmonary disease was the only statistically significant risk factor identified to increase breathlessness scores at 12 weeks.ConclusionHospitalised patients who survived COVID-19 have impaired HRQL symptoms at 12 weeks compared to their pre-COVID baseline, though were on an improving trajectory. The data highlights that COVID-19 rehabilitation services may need to consider longer programme durations with appropriate psychological and physical support and targeting individuals with pre-existing pulmonary disease may help to address the symptom chronicity. Further research is required to tailor rehabilitation services.

2.
5th Innovation and Analytics Conference and Exhibition, IACE 2021 ; 2472, 2022.
Article in English | Scopus | ID: covidwho-2050674

ABSTRACT

COVID-19 has received tremendous attention from scholars worldwide and even being labelled as a black swan event that has disrupted every aspect of human life. Within a short time span of the pandemic, a large volume of research pertaining to COVID-19 has been published in diverse research fields. This paper adopts a bibliometric analysis to systematically evaluate the research development in the application of optimization and simulation methods to address COVID-19 physical distancing policy (OSPhyD) using Bibliometrix R package. A textual query on Scopus database using the combination of four classes of keywords;covid-19, optimization, simulation, and physical distance has returned a total of 299 original research articles and reviews published in English. Appropriate visualizations were generated to describe the collaborations between different authors, countries, and institutions, whilst co-word analysis that uses text mining technique has produced a conceptual cluster via co-occurrence network map to underscore the emerging themes in the current research interest. The main findings pinpoint that: 1) OSPhyD as a scientific research field is an emerging multidisciplinary research topic that is growing progressively and steadily in the fields of medicine, engineering, social sciences, mathematics and decision science, 2) The field has attracted the attention of scholars from all over the world particularly from United States of America, United Kingdom, European countries including authors from Asia, and 3) Three dominant themes or research front emerged from the publications including COVID-19 mainstream, medical education and undergraduate. © 2022 Author(s).

3.
Gastroenterology ; 162(7):S-667-S-668, 2022.
Article in English | EMBASE | ID: covidwho-1967357

ABSTRACT

Background: The COVID-19 pandemic has allowed for the rapid expansion of telemedicine to continue to provide patients access to medical care while minimizing in-person contact. Studies have suggested that telemedicine may worsen healthcare disparities in certain segments of the population, driven in part by lack of access to appropriate technology or poor technological literacy. The aim of this study was to determine the impact of telemedicine on clinic no-show rates in the ambulatory gastroenterology setting. Methods: Single-center retrospective study of no-show visits for ambulatory in person (IP) and Telemedicine clinic appointments comparing the 15 months pre-pandemic to the first 15 months of the pandemic using an administrative database. The pre-pandemic cohort (PPC) was from January 1, 2019 to March 15, 2020 and the pandemic cohort (PC) was from March 16, 2020 to June 1, 2021. Race/ethnicity and preferred language were self-reported by patients during registration. Insurance types were categorized into private or public insurance. Statistical analysis was performed using descriptive statistics and univariate analysis. Results: There were 1841 no-show visits during the study period, 963 (52.3%) of which were PPC and 888 (48.2%) PC. In the PPC, 62.5% of these no-show visits were IP, whereas 86.8% were VV during the pandemic. The overall no-show rate decreased during the pandemic from 9.8% to 6.9% (p <0.0001). The no-show rate decreased in the PPC amongst Black (11.9 vs 8.6;p = 0.002) and Non-Hispanic White (53.8 vs 48.3, p=0.018) patients, but increased in Asian patients (8.2% vs 11.9%, p=0.007). There was a decrease in the proportion of no-show new patient appointments during the pandemic (28.2 vs 18.4, p <0.0001) along with telephone visits (22.5 vs 10.5, p<0.0001). Age >60 (OR 0.8, 95% CI 0.69-0.91, p=0.002), Hispanic ethnicity (OR 0.55, CI 0.46-0.66, p<0.00001), non-English speaking (OR 0.62, CI 0.47-0.83, p= 0.001), and follow-up appointments (OR 0.34, CI 0.28-0.4, p<0.00001) were associated with lower odds of showing up for an appointment during the pandemic period. Conclusion: When utilizing telemedicine as the primary modality for ambulatory clinic visits, there was an overall decrease in the proportion of no-show appointments during the pandemic. No show rates were improved for Black and non-Hispanic white patients but worsened for Asian patients. Elderly, Hispanic ethnicity and non-English speaking patients were also at higher risk of no-show visits during the pandemic. Future studies should aim to identify the risk factors within these populations that can be modified to improve access to healthcare. (Table Presented)

4.
Gastroenterology ; 162(7):S-475-S-476, 2022.
Article in English | EMBASE | ID: covidwho-1967315

ABSTRACT

Background: The emergence of the SARS-CoV-2 virus in December 2019, and the resultant expansion of telemedicine coverage by insurers has led to a rapid increase in telephone and video visits (VV) to meet the clinical demand while minimizing in-person contacts. The aim of this study was to identify the impact of telemedicine on access to healthcare of various subpopulations in the gastroenterology ambulatory setting. Methods: We performed a singlecenter retrospective study of ambulatory in person (IP) and Telemedicine clinic appointments comparing the 15 months pre-pandemic to the first 15 months of the pandemic using an administrative database. The pre-pandemic cohort (PPC) was from January 1, 2019 to March 15, 2020 and the pandemic cohort (PC) was from March 16, 2020 to June 1, 2021. Demographic data were collected from the electronic medical record, including self-reported race/ethnicity and preferred language during registration. Insurance types were categorized into private or public insurance (Medicare or Medicaid). Statistical analysis was performed using descriptive statistics and univariate analysis. Results: A total of 20,708 ambulatory visits were completed during the study period, 8,793 (42.4%) of which were PPC and 11,915 (57.6%) during the pandemic. In the PPC, 90.7% of visits were in person, whereas 95.2% were video visits during the pandemic. The average patient age decreased during the pandemic (50.4 vs 48.8, p <0.0001). During the pandemic, there was a significant increase in the proportion of patients seen who were female (p=0.002), age < 40 (p=0.0002), of Latinx ethnicity (p=0.12), and English speaking (p=0.0006), but there was a significant decrease in patients age > 60 (32.7% vs 29.1%, p<0.0001). There were fewer non-English speakers during the pandemic mainly driven by a decrease in Chinese speakers (p=0.002). Black patients (p<0.0001) and Spanish speakers (p=0.001) in the PC were disproportionately receiving telephone visits. In the PC, patients who held private insurance had significantly more video visits (p=0.0003), whereas patients with public insurance had significantly more in-person visits (p<0.0001) and telephone visits (p<0.0001). Conclusion: The use of telemedicine markedly increased during the pandemic for ambulatory gastroenterology clinic visits. Telemedicine during the pandemic led to significantly increased clinical encounters for English speakers, younger patients, and Latinx patients, compared to the pre-pandemic cohort. In contrast, older patients and non-English speakers experienced a decrease in clinic visits with the widespread adoption of telemedicine. Although language barriers and technological literacy are plausible explanations for these changes, further studies are needed.(Table Presented) Table 1: Patient Demographics for Completed GI Clinic Visits (Table Presented)Table 2: Demographics Differences by Visit Type Comparing Pre-pandemic to Pandemic Cohort

5.
Gastroenterology ; 162(7):S-82-S-83, 2022.
Article in English | EMBASE | ID: covidwho-1967240

ABSTRACT

Background: Rapid On-Site-Evaluation (ROSE) with an in-room pathologist (ROSE-P) has been shown to improve the diagnostic yield of specimens obtained from patients undergoing Endoscopic Ultrasound Fine Needle Aspiration Biopsy (EUS-FNAB) of pancreatic lesions. Recently, there has been an increased interest and utilization of telecytology (ROSE-T) to address social distancing during the COVID-19 pandemic and to optimize clinical workflows. With ROSE-T, a technician equipped with a video conferencing capable microscope unit prepares the EUS-FNAB cytology slides, which are then examined by Cytopathologists remotely. The purpose of this study is to compare diagnostic outcomes of ROSE-P prepandemic with ROSE-T during the COVID-19 pandemic. Methods: A single-center mixed retrospective-prospective cohort study of patients who underwent EUS-FNAB of solid pancreatic lesions with ROSE was conducted. All patients who underwent EUS-FNA were entered into a prospective database. The retrospective arm was patients who underwent ROSE-P pre-pandemic, whereas the prospective arm was patients who underwent ROSE-T during the pandemic. 165 patients in each group were needed to detect a 10% difference in diagnostic yield between the two groups, based on sample size calculation. An interim analysis was performed based on available data. Statistical analyses were performed using descriptive statistics and univariate analysis. Results: A total of 295 patients were enrolled in the study. 168 (57%) were in the ROSE-P group and 127 (43%) in the ROSE-T group. ROSE-T was associated with significantly more needle passes than ROSE-P (3.7 vs 3.0, p<0.0001). There was increased use of 22-gauge needle and decreased use of 25-gauge needles with ROSE-T during the pandemic (p = 0.012). There was no difference in age (63.4 vs 66.3, p=0.14), gender (43.5% vs 48.8 female gender, p=0.36), means mass size (27.2 vs 27.5 mm, p=0.14), mean procedure time (48.2 vs 46.2 minutes, p=0.92), adverse events (0.6% vs 0%, p=0.38), or diagnostic yield (97% vs 98.4%, p=0.38) between ROSEP and ROSE-T respectively. Conclusion: Rapid on-site evaluation using Telecytology was associated with more needle passes and more frequent use of 22-gauge needles as compared to ROSE-P;however, there was no difference in other important outcomes such as diagnostic yield, procedure time, and adverse events. (Table Presented)

6.
International Journal of Infectious Diseases ; 116:S33-S34, 2022.
Article in English | Web of Science | ID: covidwho-1800001
7.
2021 Abu Dhabi International Petroleum Exhibition and Conference, ADIP 2021 ; 2021.
Article in English | Scopus | ID: covidwho-1789284

ABSTRACT

Many of the well-established practices and procedures those were followed in the execution of Oil & Gas Industry Projects were seeing a shift towards digital transformation in recent years, which got accelerated due to the Covid-19 pandemic. Digital transformation is the adoption of digital technologies whereby the existing business processes are modified or new ones are created. This process of redefining the conventional procedures, culture and customer experience to meet the changing requirements benefit the overall business function. Redefining the process of business in the digital age is digital transformation. Digital transformation in Oil & Gas Industry is embracing of technology to reshape how oil and gas companies manage and operate their assets. The digitally-enabled and data-centric approach leads to improved productivity, higher efficiency and increased cost savings. One of the Process Transformation example in Oil & Gas sector is to conduct the Factory Inspection and Acceptance Tests remotely utilizing various digital tools available in this digital age instead of the conventional way of physical participation in the testing. Many industries were already exploring the possibilities of non-conventional work practices such as Work from Home (remotely, away from office), conducting virtual meetings with remotely located participants. These practices were still not accepted in all the industries prior to 2020. However the outbreak of Covid-19 pandemic worldwide created a need to accept these non-conventional practices of remote or virtual work. Post Covid (2020), these are widely accepted in most of the industries including Oil & Gas sector. The concept of Virtual Remote Factory Acceptance Test (FAT) is explored to overcome the unforeseen situation arose due to worldwide Covid-19 outbreak. Travel restrictions were imposed worldwide to curb the covid-19 spread, which made a halt to the normal work practices followed till then. Virtual Remote FAT is a successful alternative to the conventional way of conducting the FAT and was utilized during Covid-19 outbreak. Virtual remote FAT is successfully completed in some of the recently executed projects and this can be pursued even after the Covid crisis. © Copyright 2021, Society of Petroleum Engineers

8.
Gastroenterology ; 160(6):S-291-S-292, 2021.
Article in English | EMBASE | ID: covidwho-1594295

ABSTRACT

Background Gastrointestinal manifestations and hyperlipasemia commonly occur as part of novel coronavirus infection (COVID-19), while data on acute pancreatitis is limited to case reports. We aimed to study the prevalence of hyperlipasemia and acute pancreatitis in a large inpatient cohort of COVID-19 patients and their impact on clinical outcomes. Methods Retrospective chart review of all hospitalized patients with confirmed COVID-19 at an 8-hospital health system in Michigan, USA was performed between February 1,2020 through April 1,2020 with inclusion of patients with obtained lipase levels. Univariate analyses were performed to evaluate associations between hyperlipasemia and degree of hyperlipasemia and clinical outcomes of mechanical ventilation, intensive care unit (ICU) admission, and mortality. COVID-19 attributed pancreatitis was defined as an episode fulfilling criteria for acute pancreatitis defined earlier, a temporally associated diagnosis of COVID-19 and an exclusion of the most common etiologies of acute pancreatitis (gallstones, alcohol use, class IA/IB/II medication (by Badalov classification) use, endoscopic retrograde pancreatography, or metabolic etiologies (hypercalcemia, hypertriglyceridemia (>1000mg/ dl)). Results Prevalence of hyperlipasemia was 26.6% and of acute pancreatitis 0.33% in 301 patients with COVID-19. Patients with hyperlipasemia were older (p=0.044) and more likely to have chronic kidney disease (p=0.002) (Table 1). A total of 158 (52.5%) of patients reported at least one gastrointestinal symptom (abdominal pain, nausea, vomiting or diarrhea), and the presence of any gastrointestinal symptoms was not associated with the presence of hyperlipasemia (p=0.790). Neither presence of hyperlipasemia or its severity stratified into mild (60-120 U/L), moderate (120-180 U/L), and severe (>180 U/L) categories were associated with increased rates of mechanical ventilation, ICU admission or increased mortality (Table 2). Acute pancreatitis occurred in two patients of which one case was biliary in origin. Prevalence of COVID-19 acute pancreatitis in the reported cohort was 0.33%. Of the other patients with hyperlipasemia, 18 underwent computed tomography of the abdomen and an intra-abdominal process was identified in only two patients, with colitis identified in one patient, and ileus in another. Discussion and Conclusions Acute pancreatitis in COVID-19 patients is rare while hyperlipasemia is common. Hyperlipasemia in patients with COVID-19 is likely attributed to several non-pancreatic etiologies. Both hyperlipasemia in this population, and COVID-19 attributed acute pancreatitis do not appear to have significant impact on patients’ clinical outcomes.(Table presented) (Table presented)

9.
Pakistan Journal of Medical and Health Sciences ; 15(2):418-420, 2021.
Article in English | Scopus | ID: covidwho-1208009

ABSTRACT

Background: Corona virus disease 19 is an acute respiratory disease, the causative organism being SARS-COV-2, a novel coronavirus from china alarmed whole world. (1) and later became a pandemic. As pregnant women were equally susceptible to this infection there was a need to follow these cases closely so that guidelines can be made based on these observations. Aim: To report the clinical experience regarding course of disease in pregnant women and fetal outcome in those who delivered during the study. Methods: The clinical course of 47 pregnant women admitted in COVID isolation ward of Sir Gangaram Hospital from 8th April to 7th July were closely followed. Data regarding their demographic characteristics, clinical findings, laboratory tests, imaging studies, treatment given and neonatal and maternal outcome in patients who delivered during this period, was collected. All the data was entered on SPSS version 23 and analyzed. Results: Mean age of women was 28.4 years, ranging between 19–39 years. Mean duration of gestation was 32weeks ranging between 10 to 40 weeks. 82.9% women were multigravidas.72.3%women were educated. 78.8% patients got infected via unknown source rest from the family.42.5% infected women were asymptomatic. Out of 57%symptomatic women 6% had severe disease.76.5%pts had raised TLC while in 8.5%. Conclusion: COVID 19 is a new disease and herd immunity will take time to develop .pregnant women are equally susceptible to this infection although current study points it to be a less fatal disease in pregnant women as compared to other corona viruses but care must be taken to protect pregnant women as evidence on long term fetomaternal follow up is not available to date. © 2021 Lahore Medical And Dental College. All rights reserved.

SELECTION OF CITATIONS
SEARCH DETAIL